Dublin, Aug. 19, 2024 (GLOBE NEWSWIRE) -- The "Epinephrine Auto-Injection Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Epinephrine ...

As part of the back-to-school rush, GoodRx, a platform for medication savings, reports the demand for epinephrine (EpiPen, EpiPen Jr, Adrenaclick, Auvi-Q) auto-injectors tends to spike in the summer ...

Sempresto, Inc., a medical device company focused on transforming access to emergency medications, today announced that its ...

Stevanato has added another drug delivery technology to its portfolio, teaming up with Owen Mumford to provide customers with a two-step, single-use auto-injector that automatically adapts to a range ...

McMaster researchers will be following a pilot project being launched in Hamilton's Jackson Square shopping mall to make epinephrine auto-injectors (EAIs) available to the public. As part of the ...

An adrenaline auto-injector is an emergency treatment for anaphylaxis; serious and potentially fatal allergic reaction to insect stings, medicines, or food, among others. Anaphylaxis is an ...

CVS Health announced Thursday morning that it has cut the price of two-packs of epinephrine auto-injectors to $109.99 — roughly the price that brand-name EpiPen shots were selling for eight years ago, ...

CVS Health, which owns more than 9,600 retail pharmacies and 1,100 walk-in clinics, will offer a lower-cost generic version of the Adrenaclick epinephrine auto-injector, targeting Mylan after the ...

Add Yahoo as a preferred source to see more of our stories on Google. On August 7, the U.S. Food and Drug Administration (FDA) approved the nalmefene hydrochloride auto-injector that is used in the ...

Individuals at risk of anaphylaxis—an acute systemic hypersensitivity reaction to an allergen or trigger, typically associated with skin reactions, nausea/vomiting, difficulty breathing, and shock—are ...

People with severe allergies now have more choices for which epinephrine auto-injector to carry in case they suffer a life-threatening attack, and most pay less for it than they did when the EpiPen ...